The patient perspective on vaccine uptake in adults with psoriasis and eczema

Megan H. Noe; Marjorie Archila; John S. Barbieri; Nathaniel Goldman; Christina G. Lopez; Arash Mostaghimi; Aaron M. Scherer; Alice J. Tan; Lourdes M. Perez-Chada; Maryam M. Asgari; Joel M. Gelfand

doi:10.1007/s00403-023-02546-0

Back

The patient perspective on vaccine uptake in adults with psoriasis and eczema

Journal article

Open access

Peer reviewed

The patient perspective on vaccine uptake in adults with psoriasis and eczema

Megan H. Noe, Marjorie Archila, John S. Barbieri, Nathaniel Goldman, Christina G. Lopez, Arash Mostaghimi, Aaron M. Scherer, Alice J. Tan, Lourdes M. Perez-Chada, Maryam M. Asgari, …

Archives of Dermatological Research, Vol.315(6), pp.1583-1592

08/2023

DOI: 10.1007/s00403-023-02546-0

PMCID: PMC9904245

PMID: 36749390

Files and links (1)

url

https://doi.org/10.1007/s00403-023-02546-0View

Published (Version of record) Open Access

Abstract

Having a chronic disease is one of the most consistent factors associated with vaccine uptake for adults in the general population, but vaccination beliefs and behaviors specific to those with chronic skin diseases have not been explored. The objective of this study was to explore factors associated with vaccine uptake and barriers to vaccination in adults with psoriasis and eczema. Virtual, video-based semi-structured interviews were performed with adults who self-reported a diagnosis of psoriasis or eczema. Interviews explored themes around healthcare decision making, perceived risks/benefits to vaccination, barriers, and vaccine knowledge. Thematic analysis was used to analyze the data. Of 34 study participants, 25 participants (74%) were females and 9 (26%) were males, with a mean age of 50.8 years (SD: 16.4, range: 24–71 yrs). Half of participants ( n = 17) had psoriasis, and half ( n = 17) had eczema. Participants recognized both personal and societal benefits to vaccines. Common vaccination barriers identified were access to appointments, concerns about side effects, and misinformation. Physicians, friends/family, and media, including internet resources, were health information resources identified by patients. These results summarize the unique patient perspective around vaccine uptake in adults with eczema and psoriasis and represent an important first step in a multi-pronged approach to improve vaccination rates in adults with chronic skin diseases.

Public Health

Eczema

Original Paper

Psoriasis

Qualitative research

Vaccine

Details

Title: Subtitle: The patient perspective on vaccine uptake in adults with psoriasis and eczema
Creators: Megan H. Noe - Brigham and Women's Hospital
Marjorie Archila - Brigham and Women's Hospital
John S. Barbieri - Brigham and Women's Hospital
Nathaniel Goldman - Brigham and Women's Hospital
Christina G. Lopez - Brigham and Women's Hospital
Arash Mostaghimi - Brigham and Women's Hospital
Aaron M. Scherer - University of Iowa
Alice J. Tan - Brigham and Women's Hospital
Lourdes M. Perez-Chada - Brigham and Women's Hospital
Maryam M. Asgari - Massachusetts General Hospital
Joel M. Gelfand - University of Pennsylvania
Resource Type: Journal article
Publication Details: Archives of Dermatological Research, Vol.315(6), pp.1583-1592
DOI: 10.1007/s00403-023-02546-0
PMID: 36749390
PMCID: PMC9904245
NLM abbreviation: Arch Dermatol Res
ISSN: 0340-3696
eISSN: 1432-069X
Publisher: Springer Berlin Heidelberg
Grant note: NIA- 1K01AG065440 / ; K23-AR073932; 5K24AR069760 / ;
Language: English
Electronic publication date: 02/07/2023
Date published: 08/2023
Academic Unit: General Internal Medicine; Internal Medicine
Record Identifier: 9984365081102771

Metrics

21 Record Views

6 Times Cited - Web of Science